Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis
Author:
Affiliation:
1. Boehringer Ingelheim Pharma GmbH & Co. KG; Biberach an der Riss Germany
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.14118/fullpdf
Reference44 articles.
1. The Concise Guide to PHARMACOLOGY 2017/18: G protein-coupled receptors;Alexander;Br J Pharmacol,2017a
2. The Concise Guide to PHARMACOLOGY 2017/18: Enzymes;Alexander;Br J Pharmacol,2017b
3. Selective inhibition of autotaxin is efficacious in mouse models of liver fibrosis;Bain;J Pharmacol Exp Ther,2017
4. Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry;Baker;Anal Biochem,2001
5. Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer;Barbayianni;Prog Lipid Res,2015
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ENPP2/Autotaxin: The potential drug target for alcoholic liver disease identified through Mendelian randomization analysis;Liver International;2024-03-22
2. Lysophosphatidic acid triggers inflammation in the liver and white adipose tissue in rat models of 1-acyl-sn-glycerol-3-phosphate acyltransferase 2 deficiency and overnutrition;Proceedings of the National Academy of Sciences;2023-12-21
3. GPAT1 Deficiency in Mice Modulates NASH Progression in a Model-Dependent Manner;Cellular and Molecular Gastroenterology and Hepatology;2023-10
4. Design, synthesis and biological evaluation studies of novel anti-fibrosis agents bearing sulfoxide moiety;Bioorganic & Medicinal Chemistry;2022-12
5. Inhibition of Autotaxin Ameliorates LPA-Mediated Neuroinflammation and Alleviates Neurological Dysfunction in Acute Hepatic Encephalopathy;ACS Chemical Neuroscience;2022-09-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3